Atlas Trials

Wuling Powder for the Treatment and Underlying Mechanism of Depressive Symptoms in Patients With Parkinson's Disease

Clinical trial NCT03195231 · UNKNOWN

Trial details

NCT number
NCT03195231
Sponsor
Beijing Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Antidepressive Agents
Start date
2017-06-25
Primary completion
2019-12-15
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.